Bao Y - Search Results

1

Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis: Post Hoc Analyses from the VISUAL-1 and VISUAL-2 Trials.

Suhler EB, Thorne JE, Mittal M, Betts KA, Tari S, Camez A, Bao Y, Joshi A. Suhler EB, et al. Among authors: bao y. Ophthalmology. 2017 Dec;124(12):1799-1807. doi: 10.1016/j.ophtha.2017.06.017. Epub 2017 Jul 6. Ophthalmology. 2017. PMID: 28689898 Free article. Clinical Trial.

2

Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database.

Wendling D, Joshi A, Reilly P, Jalundhwala YJ, Mittal M, Bao Y. Wendling D, et al. Among authors: bao y. Curr Med Res Opin. 2014 Dec;30(12):2515-21. doi: 10.1185/03007995.2014.969368. Epub 2014 Oct 8. Curr Med Res Opin. 2014. PMID: 25252590

3

ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis.

van der Heijde D, Joshi A, Pangan AL, Chen N, Betts K, Mittal M, Bao Y. van der Heijde D, et al. Among authors: bao y. Rheumatology (Oxford). 2016 Jan;55(1):80-8. doi: 10.1093/rheumatology/kev267. Epub 2015 Aug 27. Rheumatology (Oxford). 2016. PMID: 26316575 Free PMC article. Clinical Trial.

4

Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delay.

Deodhar A, Mittal M, Reilly P, Bao Y, Manthena S, Anderson J, Joshi A. Deodhar A, et al. Among authors: bao y. Clin Rheumatol. 2016 Jul;35(7):1769-76. doi: 10.1007/s10067-016-3231-z. Epub 2016 Mar 18. Clin Rheumatol. 2016. PMID: 26987341 Free PMC article.

5

Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials.

Papp KA, Yang M, Sundaram M, Jarvis J, Betts KA, Bao Y, Signorovitch JE. Papp KA, et al. Among authors: bao y. Value Health. 2018 Jan;21(1):1-8. doi: 10.1016/j.jval.2017.05.025. Epub 2017 Aug 18. Value Health. 2018. PMID: 29304933 Free article.

6

Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept.

Signorovitch JE, Wu EQ, Yu AP, Gerrits CM, Kantor E, Bao Y, Gupta SR, Mulani PM. Signorovitch JE, et al. Among authors: bao y. Pharmacoeconomics. 2010;28(10):935-45. doi: 10.2165/11538370-000000000-00000. Pharmacoeconomics. 2010. PMID: 20831302

7

Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis.

Nurmohamed M, Bao Y, Signorovitch J, Trahey A, Mulani P, Furst DE. Nurmohamed M, et al. Among authors: bao y. RMD Open. 2015 May 21;1(1):e000080. doi: 10.1136/rmdopen-2015-000080. eCollection 2015. RMD Open. 2015. PMID: 26535138 Free PMC article.

8

Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate.

Emery P, Smolen JS, Ganguli A, Meerwein S, Bao Y, Kupper H, Chen N, Kavanaugh A. Emery P, et al. Among authors: bao y. Rheumatology (Oxford). 2016 Aug;55(8):1458-65. doi: 10.1093/rheumatology/kew056. Epub 2016 Apr 25. Rheumatology (Oxford). 2016. PMID: 27114561 Clinical Trial.

9

Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson's Disease: Clinical Trial Post Hoc Analyses.

Pahwa R, Aldred J, Gupta N, Terasawa E, Garcia-Horton V, Steffen DR, Kandukuri PL, Chaudhari VS, Jalundhwala YJ, Bao Y, Kukreja P, Isaacson SH. Pahwa R, et al. Among authors: bao y. Neurol Ther. 2022 Jun;11(2):711-723. doi: 10.1007/s40120-022-00332-0. Epub 2022 Feb 22. Neurol Ther. 2022. PMID: 35192177 Free PMC article.

10

Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial.

Reich K, Signorovitch J, Ramakrishnan K, Yu AP, Wu EQ, Gupta SR, Bao Y, Mulani PM. Reich K, et al. Among authors: bao y. J Am Acad Dermatol. 2010 Dec;63(6):1011-8. doi: 10.1016/j.jaad.2009.12.029. Epub 2010 Oct 8. J Am Acad Dermatol. 2010. PMID: 20933301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,133 results

Search Page

Filters